PARP cleavage as a means of assessing apoptosis.
Mullen
Peter
P
Cancer Research UK Oncology Unit, Western General Hospital, Edinburgh, UK.
D017209:Apoptosis; D015153:Blotting, Western; D005260:Female; D006801:Humans; D016376:Oligonucleotides, Antisense / Q000494:pharmacology; D010051:Ovarian Neoplasms / Q000201:enzymology / Q000235:genetics / Q000473:pathology*; D011065:Poly(ADP-ribose) Polymerases / Q000378:metabolism*; D019908:Proto-Oncogene Proteins c-raf / Q000235:genetics / Q000378:metabolism; D014407:Tumor Cells, Cultured
D016376:Oligonucleotides, Antisense; D011065:Poly(ADP-ribose) Polymerases; D019908:Proto-Oncogene Proteins c-raf